Stefan Kasper (Stefan Kasper-Virchow, S Kasper)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Venues

PloS one

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of cancer research and clinical oncology

Future oncology (London, England)

West German Cancer Centre, University Hospital Essen

This page only lists publications with an associated author ORCID identifier.

Affiliation History

West German Cancer Centre, University Hospital Essen Jul 01 2008

Germany

Professor of Medical Oncology :: Department of Medical Oncology

Publications

Thomas Seufferlein, Ludwig Lausser, Alexander Stein, Dirk Arnold, Gerald Prager, Stefan Kasper, Michael Niedermeier, Lothar Müller, Stefan Kubicka, Alexander König, Petra Büchner-Steudel, Kai Wille, Andreas W Berger, Angelika M R Kestler, Johann M Kraus, Silke D Werle, Lukas Perkhofer, Thomas J Ettrich, Hans Armin Kestler
Prediction of resistance to bevacizumab plus FOLFOX in metastatic colorectal cancer-Results of the prospective multicenter PERMAD trial. PloS one 19 (6) (2024)
Thomas Seufferlein, Ludwig Lausser, Alexander Stein, Dirk Arnold, Gerald Prager, Stefan Kasper, Michael Niedermeier, Lothar Müller, Stefan Kubicka, Alexander König, Petra Büchner-Steudel, Kai Wille, Andreas W Berger, Angelika M R Kestler, Johann M Kraus, Silke D Werle, Lukas Perkhofer, Thomas J Ettrich, Hans Armin Kestler
Prediction of resistance to bevacizumab plus FOLFOX in metastatic colorectal cancer-Results of the prospective multicenter PERMAD trial. PloS one 19 (6) (2024)
Thomas Seufferlein, Ludwig Lausser, Alexander Stein, Dirk Arnold, Gerald Prager, Stefan Kasper, Michael Niedermeier, Lothar Müller, Stefan Kubicka, Alexander König, Petra Büchner-Steudel, Kai Wille, Andreas W Berger, Angelika M R Kestler, Johann M Kraus, Silke D Werle, Lukas Perkhofer, Thomas J Ettrich, Hans Armin Kestler
Prediction of resistance to bevacizumab plus FOLFOX in metastatic colorectal cancer-Results of the prospective multicenter PERMAD trial. PloS one 19 (6) (2024)
Thomas Seufferlein, Ludwig Lausser, Alexander Stein, Dirk Arnold, Gerald Prager, Stefan Kasper, Michael Niedermeier, Lothar Müller, Stefan Kubicka, Alexander König, Petra Büchner-Steudel, Kai Wille, Andreas W Berger, Angelika M R Kestler, Johann M Kraus, Silke D Werle, Lukas Perkhofer, Thomas J Ettrich, Hans Armin Kestler
Prediction of resistance to bevacizumab plus FOLFOX in metastatic colorectal cancer-Results of the prospective multicenter PERMAD trial. PloS one 19 (6) (2024)
Arndt Stahler, Andreas Jay Kind, Christine Sers, Soulafa Mamlouk, Lothar Müller, Meinolf Karthaus, Stefan Fruehauf, Ullrich Graeven, Ludwig Fischer von Weikersthal, Greta Sommerhäuser, Stefan Kasper, Beeke Hoppe, Annika Kurreck, Swantje Held, Volker Heinemann, David Horst, Armin Jarosch, Sebastian Stinzing, Tanja Trarbach, Dominik Paul Modest
Negative Hyperselection of Resistance Mutations for Panitumumab Maintenance in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa Phase II Trial, AIO KRK 0212). Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Arndt Stahler, Andreas Jay Kind, Christine Sers, Soulafa Mamlouk, Lothar Müller, Meinolf Karthaus, Stefan Fruehauf, Ullrich Graeven, Ludwig Fischer von Weikersthal, Greta Sommerhäuser, Stefan Kasper, Beeke Hoppe, Annika Kurreck, Swantje Held, Volker Heinemann, David Horst, Armin Jarosch, Sebastian Stinzing, Tanja Trarbach, Dominik Paul Modest
Negative hyperselection of resistance mutations for panitumumab maintenance in RAS wild-type metastatic colorectal cancer (PanaMa phase II trial, AIO KRK 0212). Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Carsten Bokemeyer, Fortunato Ciardiello, Olivier Dubreuil, Joel Guigay, Stefan Kasper, Per Pfeiffer, Carmine Pinto, Kensei Yamaguchi, Takayuki Yoshino, Christoph C Zielinski, Regina Esser, Josep Tabernero
Cetuximab every 2 weeks versus standard weekly dosing administration schedule. Future oncology (London, England) (2023)
Konstantinos Grapatsas, Fabian Dörr, Hruy Menghesha, Martin Schuler, Viktor Gruenwald, Sebastian Bauer, Hartmut H-J Schmidt, Stephan Lang, Rainer Kimmig, Stefan Kasper, Natalie Baldes, Servet Bölükbas
New Prognostic Score (Essen Score) to Predict Postoperative Morbidity after Resection of Lung Metastases. Cancers 15 (17) (2023)
Funda Meric-Bernstam, Randy F Sweis, Stefan Kasper, Omid Hamid, Shailender Bhatia, Reinhard Dummer, Agostina Stradella, Georgina V Long, Anna Spreafico, Toshio Shimizu, Neeltje Steeghs, Jason John Luke, Sarah M McWhirter, Thomas Müller, Nitya Nair, Nancy Lewis, Xinhui Chen, Andrew Bean, Lisa M Kattenhorn, Marc R Pelletier, Shahneen Sandhu
Combination of the STING Agonist MIW815 and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-label, Multicenter, Phase Ib Study. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Vivian Rosery, Stephan Mika, Kurt Werner Schmid, Henning Reis, Martin Stuschke, Jürgen Treckmann, Peter Markus, Brigitte Schumacher, David Albers, Bastian Mende, Harald Lahner, Marcel Wiesweg, Martin Schuler, Jens T Siveke, Stefan Kasper
Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy. Journal of cancer research and clinical oncology (2022)
J Frikkel, M Beckmann, Nico De Lazzari, Miriam Götte, Stefan Kasper, Jörg Hense, Martin Schuler, Martin Teufel, Mitra Tewes
Changes in fatigue, barriers, and predictors towards physical activity in advanced cancer patients over a period of 12 months-a comparative study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 29 (9) (2021)
Markus Möhler, Gunnar Folprecht, Volker Heinemann, Julian Walter Holch, Annett Maderer, Stefan Kasper, Susanna Hegewisch-Becker, Jan Schröder, Friedrich Overkamp, Frank Kullmann, Wolf Otto Bechstein, Matthias Vöhringer, Robert Oellinger, Florian Lordick, Michael Geißler, Armin Schulz-Abelius, Bernhard Linz, Helga Bernhard, Andreas Paul, Irene Schmidtmann, Karin Potthoff, Carl Christoph Schimanski
Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials (LICC, CELIM, FIRE-3). International journal of cancer (2021)
J Frikkel, Miriam Götte, M Beckmann, Stefan Kasper, Jörg Hense, Martin Teufel, Martin Schuler, Mitra Tewes
Fatigue, barriers to physical activity and predictors for motivation to exercise in advanced Cancer patients. BMC palliative care 19 (1) (2020)
M Markus, A Abendroth, R Noureddine, A Paul, S Breitenbuecher, I Virchow, K W Schmid, P Markus, B Schumacher, M Wiesweg, J Wendling, B Mende, J T Siveke, M Schuler, Stefan Kasper
Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapy. Journal of cancer research and clinical oncology 147 (2) (2020)
Stefan Kasper, Jens Kisro, Martin Fuchs, Christian Müller, Armin Schulz-Abelius, Meinolf Karthaus, Mohammad-Reza Rafiyan, Alexander Stein
Safety profile of trifluridine/tipiracil monotherapy in clinical practice: results of the German compassionate-use program for patients with metastatic colorectal cancer. BMC cancer 18 (1) (2018)

Stefan Kasper.css-eqlu8i{font-size:small;padding-left:4px;} (Stefan Kasper-Virchow, S Kasper)

Publication Activity (10 Years)

Top Topics

Top Venues

Stefan Kasper (Stefan Kasper-Virchow, S Kasper)